CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases

Biocon  /  News – Posts  /  Press Releases

University of Glasgow officially Opens Mazumdar Shaw Advance Research Centre

  • Posted by: BIOCON

Biocon Biologics and Viatris Launch Abevmy® (bBevacizumab), Their Third Oncology Biosimilar, in Canada

  • Posted by: BIOCON

Biocon Q4FY22 Revenue at Rs 2,476 Cr, Up 21%; Core EBITDA at Rs 815 Cr, Up 37% ; PBT(before Exceptional Items) at Rs 384 Cr, Up 9%

  • Posted by: BIOCON

NeoBiocon Partners with Novartis to offer Vildagliptin for Diabetics in UAE

  • Posted by: BIOCON

Biocon Biologics’ Insugen® Awarded a Three-Year Contract by Ministry of Health, Malaysia

  • Posted by: BIOCON

Biocon Biologics’ Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion

  • Posted by: BIOCON

University of Glasgow Names their Flagship Research Centre After John Shaw and Kiran Mazumdar-Shaw

  • Posted by: BIOCON

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society of Edinburgh (RSE)

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society
  • Posted by: BIOCON

Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash

  • Posted by: BIOCON

Biocon Q3FY22 Revenue at Rs 2,223 Cr, Up 18%; EBITDA at Rs 537 Cr, Up 25%; Biosimilars Up 28% at Rs 981 Cr; Research Services Up 10% at Rs 641 Cr; Generics Up 7% at Rs 607 Cr

  • Posted by: BIOCON
Share
Previous Next
Close
Test Caption
Test Description goes like this